Source comparison
Kisspeptin vs PT-141: Research Peptide Comparison
Primary Receptor Target GPR54 (KISS1R) in hypothalamus MC4R and MC1R in CNS and periphery Kisspeptin acts on reproductive axis; PT-141 acts on melanocortin pathways Mechanism of Action Stimulates GnRH release → increases LH/FSH → elevates gonadal hormones Acti
This comparison does not assign a generated winner or score.
- Primary Receptor Target
- GPR54 (KISS1R) in hypothalamus
- MC4R and MC1R in CNS and periphery
- Kisspeptin acts on reproductive axis; PT-141 acts on melanocortin pathways
- Mechanism of Action
- Stimulates GnRH release → increases LH/FSH → elevates gonadal hormones
- Activates melanocortin receptors → modulates cAMP signaling in neural and vascular tissues
- Kisspeptin restores hormonal signaling; PT-141 bypasses it
- Effect on HPG Axis
- Direct upstream activation. Increases LH, FSH, testosterone/estradiol
- No effect on GnRH, LH, FSH, or gonadal steroids
- Use kisspeptin for endocrine restoration; PT-141 for non-hormonal pathways
- Typical Research Applications
- Fertility studies, pubertal models, hypogonadism protocols, ovulation induction
- Sexual behavior research, melanocortin agonism studies, vascular tone models
- Kisspeptin for reproductive endocrinology; PT-141 for CNS pharmacology
- Half-Life (Rodent Models)
- 30–90 minutes (unmodified peptide)
- 4–6 hours (cyclized structure increases stability)
- PT-141 requires less frequent dosing in prolonged protocols
- Storage After Reconstitution
- 2–8°C, use within 28 days; avoid freeze-thaw
- Both degrade at room temperature. Strict cold chain required